Pulsenmore (PLSM) Equity Ratio (2025)

Pulsenmore recorded quarterly Equity Ratio of 0.82 in Q4 2025.

Pulsenmore's Equity Ratio history runs 1 years deep, the most recent figure standing at 0.82 for Q4 2025.

  • In Q4 2025, Equity Ratio changed N/A year-over-year to 0.82; the TTM figure through Dec 2025 stood at 0.82 (changed N/A YoY), while the FY2025 annual figure was 0.82, changed N/A from the prior year.
  • Equity Ratio came in at 0.82 for Q4 2025 at Pulsenmore.
  • In the past five years, Equity Ratio ranged from a high of 0.82 in Q4 2025 to a low of 0.82 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 Pulsenmore 3.04 Mn -3.77 Mn - 0.82

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.82